Alternative Data for Inari Medical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 17,000 | Sign up | Sign up | Sign up |
| Employee Rating | 88 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,087 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,589 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,176 | Sign up | Sign up | Sign up |
| X Followers | 4,411 | Sign up | Sign up | Sign up |
| X Mentions | 3 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 61 | Sign up | Sign up | Sign up |
| Linkedin Employees | 816 | Sign up | Sign up | Sign up |
About Inari Medical
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States.
| Price | $79.97 |
| Target Price | Sign up |
| Volume | 2,360,000 |
| Market Cap | $4.68B |
| Year Range | $79.97 - $79.97 |
| Dividend Yield | 0% |
| Analyst Rating | 62% buy |
| Industry | Medical Devices |
In the news
 |
Global Peripheral Vascular Devices Market Poised for Robust Growth at a CAGR of ~6% Through 2032 as Demand for Minimally Invasive Treatments Surges | DelveInsightMarch 3 - PR Newswire UK |
2025 Competitor Analysis of Global Catheter Market: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts to 2033February 18 - GlobeNewswire |
|
Blood Clot Retrieval Devices Market to Reach US$ 5.68 Billion by 2033 as First-Pass Reperfusion Becomes the New Clinical Benchmark | Astute AnalyticaFebruary 9 - GlobeNewswire |
|
Thoracic Outlet Syndrome Market Outlook 2025–2032: Strong CAGR of 5.9% with USD 351.17 Million Valuation | Coherent Market InsightsJanuary 15 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 153M | 131M | 134M | -18M | -11M | -0.090 |
| Q2 '24 | 146M | 24M | 122M | -31M | -17M | -0.380 |
| Q1 '24 | 143M | 127M | 124M | -24M | -14M | -0.220 |
| Q4 '23 | 129M | 120M | 115M | -4.7M | -950,000 | -0.080 |
| Q3 '23 | 127M | 103M | 112M | 3.2M | 7.8M | 0.050 |
Insider Transactions View All
| Hoffman William filed to sell 238,987 shares at $61.3. January 8 '25 |
| Hoffman William filed to sell 297,912 shares at $60.1. January 8 '25 |
| Hykes Andrew filed to sell 439,310 shares at $55.7. December 20 '24 |
| Hykes Andrew filed to sell 439,910 shares at $55.2. December 20 '24 |
| Hoffman William filed to sell 441,233 shares at $56.9. December 18 '24 |
Similar companies
Read more about Inari Medical (NARI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Inari Medical
The Market Cap of Inari Medical is $4.68B.
Currently, the price of one share of Inari Medical stock is $79.97.
The NARI stock price chart above provides a comprehensive visual representation of Inari Medical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Inari Medical shares. Our platform offers an up-to-date NARI stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Inari Medical (NARI) does not offer dividends to its shareholders. Investors interested in Inari Medical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Inari Medical are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
